Arcutis Biotherapeutics, Inc. ARQT Prepaid clinical trial costs
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept arqt:PrepaidClinicalTrialTestCostsCurrent.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s prepaid clinical trial costs?
- Arcutis Biotherapeutics, Inc. (ARQT) reported prepaid clinical trial costs of $2.97M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s prepaid clinical trial costs changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s prepaid clinical trial costs decreased by 12.2% year-over-year, from $3.38M to $2.97M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s prepaid clinical trial costs?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s prepaid clinical trial costs has grown at a -11.9% compound annual growth rate (CAGR), from $4.87M to $2.58M.